Advertisement
  • Reuters

    Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data

    Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their biggest one-day fall since August 2022, after rival Amgen said it was encouraged by interim trial data on its experimental obesity drug. Novo Nordisk were last down 4.4% by 1022 GMT, having hit their lowest in two months earlier in the day. Amgen on Thursday said it was very encouraged after completing an interim analysis of its mid-stage study of experimental weight-loss drug MariTide, which, if approved, would compete Novo's Wegovy and Eli Lilly's Zepbound.

  • Yahoo TV UK

    Clarkson's Farm star Kaleb Cooper injured by his own safety equipment

    Jeremy Clarkson's farm manager is shown suffering a nasty injury in season three of the show - caused by equipment that was supposed to keep him safe.

  • Thomson Reuters StreetEvents

    Q1 2024 Ardelyx Inc Earnings Call

    Q1 2024 Ardelyx Inc Earnings Call